|
PTK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.779000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.220510E-03 |
| Normal-vs-Stage2 |
2.126400E-02 |
| Normal-vs-Stage3 |
1.768380E-01 |
| Normal-vs-Stage4 |
1.792090E-02 |
| Stage1-vs-Stage2 |
8.917000E-01 |
| Stage1-vs-Stage3 |
1.151380E-01 |
| Stage1-vs-Stage4 |
8.906400E-01 |
| Stage2-vs-Stage3 |
2.227600E-01 |
| Stage2-vs-Stage4 |
8.239400E-01 |
| Stage3-vs-Stage4 |
2.918800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.168490E-02 |
| Normal-vs-AfricanAmerican |
5.859000E-03 |
| Normal-vs-Asian |
1.458020E-03 |
| Caucasian-vs-AfricanAmerican |
2.644800E-01 |
| Caucasian-vs-Asian |
6.538400E-02 |
| AfricanAmerican-vs-Asian |
8.055800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.000800E-03 |
| Normal-vs-Female |
5.235100E-03 |
| Male-vs-Female |
3.363000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.536190E-03 |
| Normal-vs-Age(41-60Yrs) |
3.846500E-02 |
| Normal-vs-Age(61-80Yrs) |
8.601800E-03 |
| Normal-vs-Age(81-100Yrs) |
3.139400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.655020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.338200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.556000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.782800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.898400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.224000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.484200E-02 |
| Classical-VS-Follicular |
3.337800E-01 |
| Classical-VS-Other |
9.354000E-01 |
| Classical-VS-Normal |
3.441900E-04 |
| Tall-VS-Follicular |
4.018600E-01 |
| Tall-VS-Other |
4.062400E-01 |
| Tall-VS-Normal |
3.786000E-01 |
| Follicular-VS-Other |
8.101800E-01 |
| Follicular-VS-Normal |
6.244000E-02 |
| Other-VS-Normal |
1.625370E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.834000E-02 |
| Normal-vs-N1 |
2.928300E-02 |
| N0-vs-N1 |
4.220000E-01 |
|
|
